These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28797417)

  • 1. Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis.
    Hong JC; Blankstein R; Shaw LJ; Padula WV; Arrieta A; Fialkow JA; Blumenthal RS; Blaha MJ; Krumholz HM; Nasir K
    JACC Cardiovasc Imaging; 2017 Aug; 10(8):938-952. PubMed ID: 28797417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals.
    Spahillari A; Zhu J; Ferket BS; Hunink MGM; Carr JJ; Terry JG; Nelson C; Mwasongwe S; Mentz RJ; O'Brien EC; Correa A; Shah RV; Murthy VL; Pandya A
    JAMA Cardiol; 2020 Aug; 5(8):871-880. PubMed ID: 32401264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke.
    Heller DJ; Coxson PG; Penko J; Pletcher MJ; Goldman L; Odden MC; Kazi DS; Bibbins-Domingo K
    Circulation; 2017 Sep; 136(12):1087-1098. PubMed ID: 28687710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
    Pandya A; Sy S; Cho S; Weinstein MC; Gaziano TA
    JAMA; 2015 Jul; 314(2):142-50. PubMed ID: 26172894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
    Rhee EJ; Park SE; Oh HG; Park CY; Oh KW; Park SW; Blankstein R; Plutzky J; Lee WY
    Atherosclerosis; 2015 May; 240(1):242-9. PubMed ID: 25818250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of coronary artery calcium testing for coronary heart and cardiovascular disease risk prediction to guide statin allocation: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Roberts ET; Horne A; Martin SS; Blaha MJ; Blankstein R; Budoff MJ; Sibley C; Polak JF; Frick KD; Blumenthal RS; Nasir K
    PLoS One; 2015; 10(3):e0116377. PubMed ID: 25786208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts.
    Akintoye E; Afonso L; Bengaluru Jayanna M; Bao W; Briasoulis A; Robinson J
    J Am Heart Assoc; 2021 Jun; 10(12):e019589. PubMed ID: 34092110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of coronary calcium score-guided statin therapy initiation for Australians with family histories of premature coronary artery disease.
    Venkataraman P; Neil AL; Mitchell GK; Stanton T; Nicholls S; Tonkin AM; Watts GF; Marwick TH
    Med J Aust; 2023 Mar; 218(5):216-222. PubMed ID: 36841547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study.
    Galper BZ; Wang YC; Einstein AJ
    PLoS One; 2015; 10(9):e0138092. PubMed ID: 26422204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Coronary Artery Calcium Scoring for Statin Treatment Strategy according to ACC/AHA Guidelines in Asymptomatic Korean Adults.
    Han D; Ó Hartaigh B; Lee JH; Rizvi A; Park HE; Choi SY; Sung J; Chang HJ
    Yonsei Med J; 2017 Jan; 58(1):82-89. PubMed ID: 27873499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population.
    Cho YK; Jung CH; Kang YM; Hwang JY; Kim EH; Yang DH; Kang JW; Park JY; Kim HK; Lee WJ
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27543305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.
    Pletcher MJ; Lazar L; Bibbins-Domingo K; Moran A; Rodondi N; Coxson P; Lightwood J; Williams L; Goldman L
    Ann Intern Med; 2009 Feb; 150(4):243-54. PubMed ID: 19221376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV; Spahillari A; Mwasongwe S; Carr JJ; Terry JG; Mentz RJ; Addison D; Hoffmann U; Reis J; Freedman JE; Lima JAC; Correa A; Murthy VL
    JAMA Cardiol; 2017 Jun; 2(6):644-652. PubMed ID: 28315622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.
    Pletcher MJ; Pignone M; Earnshaw S; McDade C; Phillips KA; Auer R; Zablotska L; Greenland P
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):276-84. PubMed ID: 24619318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins.
    Osawa K; Trejo MEP; Nakanishi R; McClelland RL; Blaha MJ; Blankstein R; McEvoy JW; Ceponiene I; Stein JH; Sacco RL; Polak JF; Budoff MJ
    Eur J Prev Cardiol; 2018 Dec; 25(18):1980-1987. PubMed ID: 30183342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.